Category: Blood Sugar

  • Liraglutide

    Description

    This page contains brief details about the drug liraglutide, it’s indication, dosage & administaration, mechanism of action, related brands with strength, warnings and common side effects.

    Date of Approval

    Liraglutide is an anti-diabetic medication which was approved for its medical use on 25th January 2010.

    Mechanism of Action of Liraglutide

    Liraglutide is a glucagon-like peptide-1 agonist which is coupled to adenylate cyclase. GLP-1 stimulates the release of insulin and lowers glucose levels. It works by inhibiting glucagon secretion, delaying gastric emptying, and reducing the death of islet cells. It decreases hormones that raise blood sugar levels, slow digestion and reduce appetite.

    Uses of Liraglutide

    Liraglutide is a glucagon-like peptide-1 agonist which is coupled to adenylate cyclase. GLP-1 stimulates the release of insulin and lowers glucose levels. It works by inhibiting glucagon secretion, delaying gastric emptying, and reducing the death of islet cells. It decreases hormones that raise blood sugar levels, slow digestion and reduce appetite.

    Liraglutide Dosage available

    Liraglutide is available as a solution for injection in doses of 0.6 mg, 1.2 mg, or 1.8 mg. It is intended for subcutaneous administration into the abdomen or thigh. Only use if the solution is clear, colorless, and contains no particles. Do not double the dose to compensate for the one you missed. Even if the needle is replaced, avoid sharing Liraglutide with other patients.

  • Semaglutide

    Description

    This page contains brief details about the drug semaglutide, it’s indication, dosage & administaration, mechanism of action, related brands with strength, warnings and common side effects.

    Date of Approval

    Semaglutide was initially approved by the U.S. Food and Drug Administration (FDA) on December 5, 2017, for treating type 2 diabetes. Since then, it has also received additional approvals for its use in chronic weight management.

    Mechanism of Action of Semaglutide

    Semaglutide, a GLP-1 receptor agonist, exerts its therapeutic effects by mimicking the action of the naturally occurring hormone GLP-1. In diabetes management, this medication enhances insulin secretion, inhibits glucagon release, slows gastric emptying, and decreases hepatic glucose production. This medication effect leads to improved glycemic control and reduced HbA1c levels. Additionally, this medication promotes weight loss through increased satiety, decreased food intake, and modulation of gastric function. It has also demonstrated cardiovascular benefits, including potentially reducing major cardiovascular events.

    Uses of Semaglutide

    rSemaglutide is used to improve blood sugar control in type 2 diabetes and aid in weight management in individuals with obesity or overweight.

    Semaglutide Dosage available

    Semaglutide is typically administered as a subcutaneous injection at a convenient time once a week, on the same day each week. The injection can be given in the abdomen, thigh, or upper arm. These medication pens come with clear instructions on how to load the needle, dial the dose, and administer the injection. After injecting, dispose of the needle safely in a sharps container. Regular monitoring and follow-up with your healthcare provider are important to assess your progress and make any necessary adjustments to your treatment plan.